The CARE Congress on Biosimilars was a great success!


 

About the CARE Congress on Biosimilars:

On Friday, January 13th, the CARE™ Faculty specialists representing the fields of gastroenterology, hematology, oncology, respirology and rheumatology met to consider the integration of biosimilars into the Canadian healthcare system.

With biosimilars being relatively new to the Canadian landscape, there are also a number of questions/considerations on extrapolating data, interchangeability, immunogenicity, and systemic challenges (tracking and monitoring) that require attention.

Recognizing both the potential impact on the Canadian healthcare system and the importance of involving stakeholders, CARE™ faculty invited 16 speakers representing Canadian researchers, clinicians, Health Canada, public and private funding agencies, health economists, hospital pharmacists, nurses, advocacy groups, ethicists and legal experts to share perspectives, concerns, wants and needs. Over 100 people were in attendance, representing the aforementioned stakeholders, along with various levels of government, pharmaceutical companies and industry associations, listened in while speakers and assembled faculty discussed biosimilars from multiple perspectives.

Congress Chairs: 
Dr. John Marshall (CARE Gastroenterology Faculty, McMaster University) 
Dr. John Kuruvilla (CARE Hematology Faculty, Princess Margaret Cancer Centre)              

Congress Facilitator:
Dr. Hartmut Grasemann (CARE Respirology Faculty, The Hospital for Sick Children) 


Presentations

Slides are not for redistribution.

(If you are interested in a satellite meeting or presentation using the content or slides from the CARE Congress on Biosimilars, please contact info@careeducation.ca for approvals or opportunities.)

Scientific Review of Biosimilars 
Dr. Rob Laister (Princess Margaret Cancer Centre)

Review of Biosimilar Clinical Data
Dr. Vipul Jairath (Western University)

Health Canada Perspective
Jenny (Jing) Ning (Health Canada)

Public Payer Perspective
Sherry O’Quinn
Paul Grootendorst, PhD (Health Economist)

Private Payer Perspective
Laureen Rance & Kim MacFarlane (Manulife)

Advocacy Group Perspective
Eric Thomson (Crohn’s & Colitis Canada), 
Elizabeth Lye (Lymphoma Canada), 
Martine Elias (Myeloma Canada)

aHCP Perspective
Scott Edwards, PharmD )Dr. H. Bliss Murphy Cancer Centre),
Usha Chauhan, NP (McMaster),  

Diana Incekol, RN (CANO/ACIO),
Ruth Turner, NP (Princess Margaret Cancer Centre), 

Legal & Ethical Perspective
Eileen McMahon (Tory Law Firm), 
Durhane Wong-Reiger (AdvoCare) 

     

CARE Congress Report on Biosimilars


Thank you to the sponsors of this event:
For a list of sponsors and supporters of CARE, please click here. 


Don't miss out!
Receive updates and follow-up information from the
CARE Congress on Biosimilars by signing up for our mailing list below:

Name *
Name